NIDHOG — Nidhogg Resources Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK4.72m
- SEK3.85m
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate
Brief: Eurocine Vaccines Enters Into Agreement With Flerie Invest To Secure Exercise Of Warrants Of Series To 4
Brief: Eurocine Vaccines Resolves On Scientific Advice With The Swedish Medical Products Agency Ahead Of Clinical Trial Application
Brief: Eurocine Vaccines AB - Result After Tax During First Half At -7,6 Msek
Vaccine-averse Tanzania told to follow science
Covid: 19 vaccine delays may slow wider Irish roll-out, says PM
Vaccine manufacturing is lumpy, supply not as good as hoped, UK says (updated)
Brief: Eurocine Vaccines Says Collaborated With Biovian For Chlamydia Vaccine Candidate
Brief: Eurocine Vaccines Has Selected Biovian As Contract Developer For The Chlamydia Vaccine Candidate
Vaccine, financial relief near as coronavirus ravages U.S. health, economy (updated)
Brief: Eurocine Vaccines Signs Evaluation Agreement
Brief: Eurocine Vaccines Q1 Loss After Tax Widens To SEK 3.2 Mln
Analysis: Dow cracks 30,000, a psychological boost during a pandemic
Analysis: Dow cracks 30,000, a psychological boost during a pandemic
Brief: Eurocine Vaccines Q4 Net Loss Narrows To SEK 2.5 Million
Brief: Eurocine Vaccines Enters Into Research And Collaboration Agreement With Spixia Biotechnology